Cover
Cover - USD ($) | 12 Months Ended | |
Dec. 31, 2021 | Jun. 30, 2021 | |
Cover [Abstract] | ||
Document Type | 10-K | |
Amendment Flag | false | |
Document Annual Report | true | |
Document Transition Report | false | |
Document Period End Date | Dec. 31, 2021 | |
Document Fiscal Period Focus | FY | |
Document Fiscal Year Focus | 2022 | |
Current Fiscal Year End Date | --12-31 | |
Entity File Number | 000-55818 | |
Entity Registrant Name | BIOCRUDE TECHNOLOGIES USA, INC. | |
Entity Central Index Key | 0001690384 | |
Entity Tax Identification Number | 81-2924160 | |
Entity Incorporation, State or Country Code | NV | |
Entity Address, Address Line One | 605-1255 Phillips Square | |
Entity Address, City or Town | Montreal | |
Entity Address, Country | CA | |
Entity Address, Postal Zip Code | H3B 3G5 | |
City Area Code | 514 | |
Local Phone Number | 840-9719 | |
Title of 12(g) Security | Common Stock, $0.001 par value | |
Entity Well-known Seasoned Issuer | No | |
Entity Voluntary Filers | No | |
Entity Current Reporting Status | No | |
Entity Interactive Data Current | No | |
Entity Filer Category | Non-accelerated Filer | |
Entity Small Business | true | |
Entity Emerging Growth Company | false | |
Entity Shell Company | false | |
Entity Public Float | $ 0 | |
Entity Common Stock, Shares Outstanding | 50,710,386 | |
Auditor Name | BF Borgers CPA PC | |
Auditor Location | Lakewood, CO | |
Auditor Firm ID | 5041 |
CONSOLIDATED BALANCE SHEETS
CONSOLIDATED BALANCE SHEETS - USD ($) | Dec. 31, 2021 | Dec. 31, 2020 |
CURRENT ASSETS | ||
Cash | $ 1,778 | $ 109,971 |
Property, plant and equipment | 20,854 | 19,697 |
TOTAL ASSETS | 22,632 | 129,668 |
CURRENT LIABILITIES | ||
Accounts payable and accrued liabilities | 16,424 | 21,400 |
Accounts payable and accrued liabilities - related parties (Note 6) | 41,664 | 104,727 |
Convertible notes (Note 3) | ||
Loans payable (Note 4) | 138,394 | 152,169 |
TOTAL LIABILITIES | 196,482 | 278,296 |
STOCKHOLDERS’ DEFICIT | ||
Common stock, $0.001 par value, 75,000,000 shares authorized, 50,710,386 and outstanding (December 31, 2020 - 50,621,336) | 50,711 | 50,622 |
Additional paid in capital | 8,523,756 | 8,167,646 |
Subscription receivable | (50,000) | |
Accumulated other comprehensive income | 28,678 | 28,654 |
Deficit | (8,774,402) | (8,343,939) |
TOTAL STOCKHOLDERS’ DEFICIT ATTRIBUTALBLE TO EQUITY SHAREHOLDERS’ OF THE COMPANY | ||
NON-CONTROLLING INTEREST | (2,593) | (1,611) |
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT | $ 22,632 | $ 129,668 |
CONSOLIDATED BALANCE SHEETS (Pa
CONSOLIDATED BALANCE SHEETS (Parenthetical) - $ / shares | Dec. 31, 2021 | Dec. 31, 2020 |
Statement of Financial Position [Abstract] | ||
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common stock, authorized | 75,000,000 | 75,000,000 |
Common stock, outstanding | 50,710,386 | 50,621,336 |
CONSOLIDATED STATEMENTS OF OPER
CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS - USD ($) | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
OPERATING EXPENSES | ||
General and administrative expenses | $ 427,330 | $ 283,735 |
LOSS FROM OPERATIONS | (427,330) | (283,735) |
Accretion and Interest expense | (4,125) | (4,750) |
Income tax expense (Note 5) | ||
NET LOSS | (431,455) | (288,485) |
OTHER COMPREHENSIVE LOSS | ||
Translation to reporting currency | 34 | (24) |
TOTAL COMPREHENSIVE LOSS | (431,421) | (288,509) |
NET LOSS ATTRIBUTALBE TO | ||
Equity shareholders of the Company | (430,463) | (288,485) |
Non-controlling interest | (992) | |
NET LOSS | (431,455) | (288,485) |
TOTAL COMPREHENSIVE LOSS ATTRIBUTABLE TO | ||
Equity shareholders of the Company | (430,439) | (288,502) |
Non-controlling interest | $ (982) | $ (7) |
Loss per share - basic and diluted | $ (0.01) | $ (0.01) |
Weighted average number of shares outstanding – basic and diluted | 50,689,793 | 50,516,852 |
CONSOLIDATED STATEMENTS OF CHAN
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT - USD ($) | Common Stock [Member] | Additional Paid-in Capital [Member] | AOCI Attributable to Parent [Member] | Deficit [Member] | Total Equity Attributable To Equity Shareholders Company Of The [Member] | Noncontrolling Interest [Member] | Total |
Beginning balance, value at Dec. 31, 2019 | $ 50,484 | $ 7,617,783 | $ 28,671 | $ (8,055,454) | $ (358,516) | $ (1,604) | $ (360,120) |
Beginning balance, shares at Dec. 31, 2019 | 50,483,836 | ||||||
Subscription Receivable | (50,000) | (50,000) | |||||
Stock issued for services | $ 30 | 119,970 | 120,000 | 120,000 | |||
Stock issued for services (in shares) | 30,000 | ||||||
Stock issued for conv. debts | |||||||
Stock issued for cash | $ 108 | 429,893 | 430,000 | 430,000 | |||
Stock issued for cash (in shares) | 107,500 | ||||||
Beneficial conversion feature | |||||||
Foreign currency translation gain | (17) | (17) | (7) | (24) | |||
Net loss | (288,485) | (288,485) | (288,485) | ||||
Ending balance, value at Dec. 31, 2020 | $ 50,622 | 8,167,646 | 28,654 | (8,343,939) | (147,017) | (1,611) | (148,628) |
Ending balance, shares at Dec. 31, 2020 | 50,621,336 | ||||||
Subscription Receivable | 50,000 | 50,000 | |||||
Stock issued for services | $ 47 | 186,153 | 186,200 | 186,200 | |||
Stock issued for services (in shares) | 46,550 | ||||||
Stock issued for cash | $ 43 | 169,957 | 170,000 | 170,000 | |||
Stock issued for cash (in shares) | 42,500 | ||||||
Beneficial conversion feature | |||||||
Foreign currency translation gain | 24 | 24 | 10 | 34 | |||
Net loss | (430,463) | (430,463) | (992) | (431,455) | |||
Ending balance, value at Dec. 31, 2021 | $ 50,622 | $ 8,523,756 | $ 28,678 | $ (8,774,402) | $ (171,257) | $ (2,593) | $ (173,850) |
Ending balance, shares at Dec. 31, 2021 | 50,710,386 |
CONSOLIDATED STATEMENTS OF CASH
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
CASH FLOWS FROM OPERATING ACTIVITIES: | ||
Net loss | $ (431,455) | $ (288,485) |
Adjustments to reconcile net loss to net cash used in operating activities | ||
Accretion and interest expenses | 4,126 | 4,751 |
Amortization | 3,935 | 4,055 |
Stock issued for services | 186,198 | 120,000 |
Forgiveness accrued interest | ||
Foreign exchange | (5,031) | (15,933) |
Changes in operating assets and liabilities | ||
Prepaid expenses | ||
Accounts payable and accruals | (4,976) | (6,838) |
Accounts payable and accrued liabilities - related party | (63,063) | (97,134) |
Net cash used in operating activities | (310,266) | (279,584) |
Proceeds from private placement | 220,000 | 380,000 |
Proceeds of loans payable | (12,835) | 9,250 |
Net cash provided by financing activities | 207,165 | 389,250 |
CASH FLOWS FROM INVESTING ACTIVITIES: | ||
Purchase of property, plant and equipment | (5,092) | |
Net cash used in financing activities | (5,092) | |
Effect of exchange rate changes on cash | ||
CHANGE IN CASH DURING THE YEAR | (108,193) | 109,666 |
CASH BEGINNING | 109,971 | 305 |
CASH ENDING | 1,778 | 109,971 |
SUPPLEMENTAL DISCLOSURE OF CASH FLOW INFORMATION: | ||
Cash paid for income taxes | ||
Interest paid | ||
Noncash investing and financing activities: | ||
Beneficial conversion feature discount related to the issuance of convertible debt | ||
Conversion of convertible debt to common stock | ||
Stock issued for services | 186,200 | 66,000 |
Forgiveness accrued interest | $ 0 | $ 0 |
ORGANIZATION AND BASIS OF PRESE
ORGANIZATION AND BASIS OF PRESENTATION | 12 Months Ended |
Dec. 31, 2021 | |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | |
ORGANIZATION AND BASIS OF PRESENTATION | NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION Nature of Operations Biocrude Technologies USA, Inc. (the ‘Company’) was incorporated under the laws of the State of Nevada on December 29, 2015. The Company’s principal business objective is to provide resource management expertise and services, catering to commercial, municipal, and industrial customers, primarily in the areas of solid waste management and recycling services. Going Concern The Company’s consolidated financial statements are prepared on a going concern basis in accordance with United States generally accepted accounting principles (‘US GAAP’) which contemplate the realization of assets and discharge of liabilities and commitments in the normal course of business. The Company has not generated operating revenues to date, and has accumulated losses of $ 8,774,402 |
SUMMARY OF SIGNIFICANT ACCOUNTI
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES | NOTE 2 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Basis of presentation and Principles of Consolidation These consolidated financial statements and related notes are presented in accordance with US GAAP and are presented in United States dollars. The accompanying consolidated financial statements include the accounts of its 70% owned subsidiary, Biocrude Technologies (Hong Kong) Limited (‘Biocrude HK’). All significant inter-company transactions and balances have been eliminated upon consolidation. Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant areas requiring management’s estimates and assumptions include determining the fair value of transactions involving shares common stock. Actual results could differ from those estimates. Reclassifications Certain prior period amounts in the accompanying audited consolidated financial statements have been reclassified to conform to the current period’s presentation. These reclassifications had no effect on the results of operations or financial position for any period presented. Fair Value Measurements The Company adopted the provisions of ASC Topic 820, ‘Fair Value Measurements and Disclosures’, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements. The estimated fair value of certain financial instruments, including cash and cash equivalents, payables to related parties, and accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that be used to measure fair value: Level 1 - quoted prices in active markets for identical assets or Level 2 - quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 - inputs that are unobservable (for example cash flow modeling inputs based on assumptions) The Company’s financial assets and liabilities are subsequent measured at amortized cost, but their carrying amount approximates their fair value due to the short period of time until maturity. Foreign Currency Translation and Transaction The Company’s functional currency was the United Stated dollar. Biocrude HK maintain its accounting records in its local currency, the Hong Kong dollar. Foreign exchange gains and losses on the settlement of foreign currency transactions are included in foreign exchange expense. Except for translations of intercompany balances, all translations of monetary balances to the functional currency at the year-end exchange rate are included in foreign exchange expense. The translations of intercompany balances to the functional currency at the year-end exchange rate are included in accumulated other comprehensive income or loss. The Company has not, to the date of these consolidated financial statements, entered into derivative instruments to offset the impact of foreign currency fluctuations. Cash and cash equivalents Cash and cash equivalents consist of cash balances and highly-liquid instruments with an original maturity of three months or less. As at December 31, 2021 and 2020, the Company does no Property, plant and equipment Property, plant and equipment are recorded at cost and depreciated to its estimated residual values using the straight-line method over its estimated useful lives of 8 Share-based Expense ASC 718, ‘ Compensation – Stock Compensation The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, ‘ Equity – Based Payments to Non-Employees.’ Income Taxes Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income for the years in which those differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income statement in the period that includes the date of enactment. Additionally, ASC 740: Income Taxes, requires the Company to recognize in its financial statements the impact of a tax position that is more likely than not to be sustained upon examination based on the technical merits of the position. Earnings Per Share Information FASB ASC 260, ‘Earnings Per Share’ provides for calculation of ‘basic’ and ‘diluted’ earnings per share. Basic earnings per share includes no dilution and is computed by dividing net loss available to common shareholders by the weighted average common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity similar to fully diluted earnings per share. Basic and diluted loss per share were the same, at the reporting dates, as there were no common stock equivalents outstanding. |
STOCKHOLDER_S DEFICIT
STOCKHOLDER’S DEFICIT | 12 Months Ended |
Dec. 31, 2021 | |
Equity [Abstract] | |
STOCKHOLDER’S DEFICIT | NOTE 3 – STOCKHOLDER’S DEFICIT Common stock The authorized common stock of the Company consists of 75,000,000 0.001 During the year ended December 31, 2021, the Company issued 46,550 186,200 During the year ended December 31, 2021, the Company issued 42,500 170,000 |
CONVERTIBLE NOTES
CONVERTIBLE NOTES | 12 Months Ended |
Dec. 31, 2021 | |
Debt Disclosure [Abstract] | |
CONVERTIBLE NOTES | NOTE 4 – CONVERTIBLE NOTES During the year ended December 31, 2021, the Company did not issue any convertible notes. |
LOANS PAYABLE
LOANS PAYABLE | 12 Months Ended |
Dec. 31, 2021 | |
Loans Payable | |
LOANS PAYABLE | NOTE 5 – LOANS PAYABLE As at December 31, 2021, the Company has loans payable of $ 108,580 126,481 29,814 25,688 4 December 31, 2022 25,336 32,291 |
INCOME TAXES
INCOME TAXES | 12 Months Ended |
Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
INCOME TAXES | NOTE 6 - INCOME TAXES The Company has established a valuation allowance against deferred tax assets due to the uncertainty surrounding the realization of such assets as evidenced by the cumulative losses from operations through December 31, 2021. Management periodically evaluates the recoverability of the deferred tax assets. At such time as it is determined that it is more likely than not that deferred assets are realizable, the valuation allowance will be reduced accordingly and recorded as a tax benefit. A reconciliation of income taxes at statutory rates is as follows: Schedule of reconciliation of income taxes at statutory rates Years Ended December 31, 2021 2020 LOSS BEFORE INCOME TAXES $ (431,455 ) $ (288,485 ) Statutory tax rate 21 % 21 % Expected recovery at statutory rate (90,606 ) (60,582 ) Non-deductible expenses — — Temporal differences 827 1,405 Change in valuation allowance 89,779 59,177 Income tax expense $ — $ — The Company’s tax-effected deferred income tax assets and liabilities are estimated as follows: Schedule of deferred income tax assets and liabilities Years Ended December 31, 2021 2020 Non-capital losses $ (692,000 ) $ (602,000 ) Valuation allowance 692.000 602,000 Net deferred tax asset $ — $ — The Company has non-capital losses carried forward of approximately $ 3,293,000 between 2029 and 2041 |
RELATED PARTY TRANSACTIONS
RELATED PARTY TRANSACTIONS | 12 Months Ended |
Dec. 31, 2021 | |
Related Party Transactions [Abstract] | |
RELATED PARTY TRANSACTIONS | NOTE 7 - RELATED PARTY TRANSACTIONS As at December 31, 2021, the ‘CEO’ of the Company and a director had advanced the Company a cumulative $ 41,664 104,727 amounts are unsecured without interest payable on demand |
SUBSEQUENT EVENTS
SUBSEQUENT EVENTS | 12 Months Ended |
Dec. 31, 2021 | |
Subsequent Events [Abstract] | |
SUBSEQUENT EVENTS | NOTE 8 – SUBSEQUENT EVENTS Subsequent to December 31, 2021, the Company issued 12,500 50,000 |
SUMMARY OF SIGNIFICANT ACCOUN_2
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) | 12 Months Ended |
Dec. 31, 2021 | |
Accounting Policies [Abstract] | |
Basis of presentation and Principles of Consolidation | Basis of presentation and Principles of Consolidation These consolidated financial statements and related notes are presented in accordance with US GAAP and are presented in United States dollars. The accompanying consolidated financial statements include the accounts of its 70% owned subsidiary, Biocrude Technologies (Hong Kong) Limited (‘Biocrude HK’). All significant inter-company transactions and balances have been eliminated upon consolidation. |
Use of Estimates | Use of Estimates The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Significant areas requiring management’s estimates and assumptions include determining the fair value of transactions involving shares common stock. Actual results could differ from those estimates. |
Reclassifications | Reclassifications Certain prior period amounts in the accompanying audited consolidated financial statements have been reclassified to conform to the current period’s presentation. These reclassifications had no effect on the results of operations or financial position for any period presented. |
Fair Value Measurements | Fair Value Measurements The Company adopted the provisions of ASC Topic 820, ‘Fair Value Measurements and Disclosures’, which defines fair value as used in numerous accounting pronouncements, establishes a framework for measuring fair value and expands disclosure of fair value measurements. The estimated fair value of certain financial instruments, including cash and cash equivalents, payables to related parties, and accounts payable and accrued expenses are carried at historical cost basis, which approximates their fair values because of the short-term nature of these instruments. ASC 820 defines fair value as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. ASC 820 also establishes a fair value hierarchy, which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. ASC 820 describes three levels of inputs that be used to measure fair value: Level 1 - quoted prices in active markets for identical assets or Level 2 - quoted prices for similar assets and liabilities in active markets or inputs that are observable Level 3 - inputs that are unobservable (for example cash flow modeling inputs based on assumptions) The Company’s financial assets and liabilities are subsequent measured at amortized cost, but their carrying amount approximates their fair value due to the short period of time until maturity. |
Foreign Currency Translation and Transaction | Foreign Currency Translation and Transaction The Company’s functional currency was the United Stated dollar. Biocrude HK maintain its accounting records in its local currency, the Hong Kong dollar. Foreign exchange gains and losses on the settlement of foreign currency transactions are included in foreign exchange expense. Except for translations of intercompany balances, all translations of monetary balances to the functional currency at the year-end exchange rate are included in foreign exchange expense. The translations of intercompany balances to the functional currency at the year-end exchange rate are included in accumulated other comprehensive income or loss. The Company has not, to the date of these consolidated financial statements, entered into derivative instruments to offset the impact of foreign currency fluctuations. |
Cash and cash equivalents | Cash and cash equivalents Cash and cash equivalents consist of cash balances and highly-liquid instruments with an original maturity of three months or less. As at December 31, 2021 and 2020, the Company does no |
Property, plant and equipment | Property, plant and equipment Property, plant and equipment are recorded at cost and depreciated to its estimated residual values using the straight-line method over its estimated useful lives of 8 |
Share-based Expense | Share-based Expense ASC 718, ‘ Compensation – Stock Compensation The Company accounts for stock-based compensation issued to non-employees and consultants in accordance with the provisions of ASC 505-50, ‘ Equity – Based Payments to Non-Employees.’ |
Income Taxes | Income Taxes Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income for the years in which those differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income statement in the period that includes the date of enactment. Additionally, ASC 740: Income Taxes, requires the Company to recognize in its financial statements the impact of a tax position that is more likely than not to be sustained upon examination based on the technical merits of the position. |
Earnings Per Share Information | Earnings Per Share Information FASB ASC 260, ‘Earnings Per Share’ provides for calculation of ‘basic’ and ‘diluted’ earnings per share. Basic earnings per share includes no dilution and is computed by dividing net loss available to common shareholders by the weighted average common shares outstanding for the period. Diluted earnings per share reflect the potential dilution of securities that could share in the earnings of an entity similar to fully diluted earnings per share. Basic and diluted loss per share were the same, at the reporting dates, as there were no common stock equivalents outstanding. |
INCOME TAXES (Tables)
INCOME TAXES (Tables) | 12 Months Ended |
Dec. 31, 2021 | |
Income Tax Disclosure [Abstract] | |
Schedule of reconciliation of income taxes at statutory rates | Schedule of reconciliation of income taxes at statutory rates Years Ended December 31, 2021 2020 LOSS BEFORE INCOME TAXES $ (431,455 ) $ (288,485 ) Statutory tax rate 21 % 21 % Expected recovery at statutory rate (90,606 ) (60,582 ) Non-deductible expenses — — Temporal differences 827 1,405 Change in valuation allowance 89,779 59,177 Income tax expense $ — $ — |
Schedule of deferred income tax assets and liabilities | Schedule of deferred income tax assets and liabilities Years Ended December 31, 2021 2020 Non-capital losses $ (692,000 ) $ (602,000 ) Valuation allowance 692.000 602,000 Net deferred tax asset $ — $ — |
ORGANIZATION AND BASIS OF PRE_2
ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($) | Dec. 31, 2021 | Dec. 31, 2020 |
Organization, Consolidation and Presentation of Financial Statements [Abstract] | ||
Accumulated losses | $ 8,774,402 | $ 8,343,939 |
SUMMARY OF SIGNIFICANT ACCOUN_3
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Details Narrative) - USD ($) | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Accounting Policies [Abstract] | ||
Cash equivalents | $ 0 | $ 0 |
Property, plant and equipment useful lives | 8 years |
STOCKHOLDER_S DEFICIT (Details
STOCKHOLDER’S DEFICIT (Details Narrative) - USD ($) | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Common stock, authorized | 75,000,000 | 75,000,000 |
Common stock, par value (in dollars per share) | $ 0.001 | $ 0.001 |
Common Stock [Member] | ||
Accumulated Other Comprehensive Income (Loss) [Line Items] | ||
Stock issued for cash | 46,550 | 30,000 |
Common stock fair value | $ 186,200 | |
Stock issued for services (in shares) | 42,500 | |
Cash proceeds | $ 170,000 |
LOANS PAYABLE (Details Narrativ
LOANS PAYABLE (Details Narrative) - USD ($) | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Short-term Debt [Line Items] | ||
Loans payable | $ 108,580 | $ 126,481 |
Accrued interest | 29,814 | 25,688 |
Director [Member] | ||
Short-term Debt [Line Items] | ||
Loans payable | $ 25,336 | $ 32,291 |
Loans Payable [Member] | ||
Short-term Debt [Line Items] | ||
Interest rate | 4.00% | |
Maturity date | Dec. 31, 2022 |
INCOME TAXES (Details)
INCOME TAXES (Details) - USD ($) | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Income Tax Disclosure [Abstract] | ||
LOSS BEFORE INCOME TAXES | $ (431,455) | $ (288,485) |
Statutory tax rate | 21.00% | 21.00% |
Expected recovery at statutory rate | $ (90,606) | $ (60,582) |
Non-deductible expenses | ||
Temporal differences | 827 | 1,405 |
Change in valuation allowance | 89,779 | 59,177 |
Income Tax Expense |
INCOME TAXES (Details 1)
INCOME TAXES (Details 1) - USD ($) | Dec. 31, 2021 | Dec. 31, 2020 |
Income Tax Disclosure [Abstract] | ||
Non-capital losses | $ (692,000) | $ (602,000) |
Valuation allowance | 692 | 602,000 |
Net deferred tax asset |
INCOME TAXES (Details Narrative
INCOME TAXES (Details Narrative) | 12 Months Ended |
Dec. 31, 2021USD ($) | |
Income Tax Disclosure [Abstract] | |
Non-capital losses carried forward | $ 3,293,000 |
Income tax expiration Period | between 2029 and 2041 |
RELATED PARTY TRANSACTIONS (Det
RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($) | 12 Months Ended | |
Dec. 31, 2021 | Dec. 31, 2020 | |
Chief Executive Officer [Member] | ||
Related Party Transaction [Line Items] | ||
Advances from related parties | $ 41,664 | $ 104,727 |
Related Parties [Member] | Loans Payable [Member] | ||
Related Party Transaction [Line Items] | ||
Description of collateral | amounts are unsecured | |
Description of interest rate terms | without interest | |
Description of repayment terms | payable on demand |
SUBSEQUENT EVENTS (Details Narr
SUBSEQUENT EVENTS (Details Narrative) - USD ($) | 1 Months Ended | 12 Months Ended | |
Jan. 23, 2022 | Dec. 31, 2021 | Dec. 31, 2020 | |
Subsequent Event [Line Items] | |||
Issaunce of shares | 12,500 | ||
Stock issued for cash | $ 170,000 | $ 430,000 | |
Subsequent Event [Member] | |||
Subsequent Event [Line Items] | |||
Stock issued for cash | $ 50,000 |